Friedman H, Greenblatt D J, Scavone J M, Burstein E S, Ochs H R, Harmatz J S, Shader R I
Department of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts.
Clin Pharmacokinet. 1989 May;16(5):312-6. doi: 10.2165/00003088-198916050-00003.
A single oral dose of doxylamine succinate 25 mg was administered to 21 young (20 to 43 years) and 22 elderly (60 to 87 years) volunteers. Multiple plasma doxylamine concentrations were determined during a 30-hour period after each dose. Elderly and young women did not differ significantly in peak plasma doxylamine concentration (Cmax) [116 vs 103 micrograms/L], time to Cmax (tmax) [2.4 vs 2.4 h], elimination half-life (12.2 vs 10.1 h), volume of distribution (179 vs 176 L) or clearance (191 vs 218 ml/min). Cmax (107 vs 108 micrograms/L) and tmax (2.1 vs 1.6 h) also did not differ between elderly and young men. However, elderly men had reduced doxylamine clearance (174 vs 240 ml/min, p less than 0.02; 2.5 vs 3.2 ml/min/kg, p less than 0.07) and prolonged half-life (15.5 vs 10.2 h, p less than 0.05). The reduced doxylamine clearance and prolonged half-life in elderly men, but not in elderly women, is similar to results for many other drugs which are transformed by oxidation.
对21名年轻(20至43岁)志愿者和22名老年(60至87岁)志愿者口服给予25毫克琥珀酸多西拉敏单剂量。在每次给药后的30小时内测定多次血浆多西拉敏浓度。老年女性和年轻女性在血浆多西拉敏峰值浓度(Cmax)[116对103微克/升]、达峰时间(tmax)[2.4对2.4小时]、消除半衰期(12.2对10.1小时)、分布容积(179对176升)或清除率(191对218毫升/分钟)方面无显著差异。老年男性和年轻男性之间的Cmax(107对108微克/升)和tmax(2.1对1.6小时)也无差异。然而,老年男性的多西拉敏清除率降低(174对240毫升/分钟,p<0.02;2.5对3.2毫升/分钟/千克,p<0.07)且半衰期延长(15.5对10.2小时,p<0.05)。老年男性而非老年女性中多西拉敏清除率降低和半衰期延长的情况与许多其他经氧化代谢的药物的结果相似。